When Will Fondaparinux Induce Thrombocytopenia?
When Will Fondaparinux Induce Thrombocytopenia?
复制标题
DOI:
10.1021/acs.bioconjchem.2c00316
复制
发表时间:
2022-08-17
影响因子:
4.7
通讯作者:
Nguyen, Thi-Huong
中科院分区:
文献类型:
--
作者:
Chen, Li-Yu;Khan, Nida;Lindenbauer, Annerose;Nguyen, Thi-Huong
The pentasaccharide Fondaparinux, a synthetic selective factor Xa inhibitor, is one of the safest anticoagulants in the heparin family that is recommended as an alternative drug for patients with hypersensitivity to other drugs such as heparin-induced thrombocytopenia (HIT). However, some observations of Fondaparinux-induced thrombocytopenia (FIT) have been reported while others claimed that FIT does not occur in patients with fondaparinux therapy, indicating that the mechanism of FIT remains controversial. Here, we utilized different methodologies including dynamic light scattering, immunosorbent and platelet aggregation assays, confocal laser scanning microscopy, and flow cytometry to gain insights into FIT. We found that at a certain concentration, Fondaparinux formed sufficient large and stable complexes with PF4 that facilitated binding of the HIT-like monoclonal KKO antibody and enhanced platelet aggregation and activation. We proposed a model to describe the role of Fondaparinux concentration in the formation of complexes with platelet factor 4 and how it promotes the binding of KKO. Our results clarify controversial observations of FIT in patients as each contains a dissimilar PF4:Fondaparinux concentration ratio.
登录
查看更多内容
影响因子:
16.6
作者:
Cai Z;Yarovoi SV;Zhu Z;Rauova L;Hayes V;Lebedeva T;Liu Q;Poncz M;Arepally G;Cines DB;Greene MI
通讯作者:
Greene MI
影响因子:
6.9
作者:
Peysselon, Franck;Ricard-Blum, Sylvie
通讯作者:
Ricard-Blum, Sylvie
影响因子:
3
作者:
Russo, Vincenzo;Cardillo, Giuseppe;Di Micco, Pierpaolo
通讯作者:
Di Micco, Pierpaolo
影响因子:
2.9
作者:
Ahmad, S;Jeske, WP;Fareed, J
通讯作者:
Fareed, J
影响因子:
2.7
作者:
Bauer, KA
通讯作者:
Bauer, KA